Phenprocoumon Dose Requirements, Dose Stability and Time in Therapeutic Range in Elderly Patients With <i>CYP2C9</i> and <i>VKORC1</i> Polymorphisms.

Front Pharmacol · 2019 · PMC6997201 · PMID 32047440

Europe PMC DOI

hedged sentence

0.0737

closest p · 1.5× alpha

0.0737

boldest claim

The sentences

did not reach statistical significancep = 0.0737so close (0.05 < p ≤ 0.1)

Additionally, *3 carriers were observed to receive constant phenprocoumon doses more frequently than wildtypes or *2 carriers, but this results did not reach statistical significance (p = 0.0737).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.